Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Tyra Biosciences, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 51 | 59 | +8 |
| Shares | 35.7M | 36.2M | +556.5K (+1.6%) |
| Value | $573.0M | $616.7M | +$43.7M (+7.6%) |
New holders (8)
Institutions that held Tyra Biosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Auour Investments LLC | 85,020 | $1.45M | 0.61% |
| Dimensional Fund Advisors LP | 10,601 | $180.5K | 0.00% |
| Boothbay Fund Management, LLC | 10,174 | $173.3K | 0.01% |
| Exchange Traded Concepts, LLC | 8,867 | $151.0K | 0.00% |
| Citigroup Inc | 4,165 | $70.9K | 0.00% |
| Allspring Global Investments Holdings, LLC | 2,273 | $38.7K | 0.00% |
| Simplex Trading, LLC | 674 | $11.0K | 0.00% |
| Russell Investments Group, Ltd. | 176 | $3.00K | 0.00% |
Sold out (0)
Institutions that held Tyra Biosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
None.